Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Growth in Pediatric ESRD
NCT05926570Phase 4Completed
- Sponsor
- Tanta University
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Tanta University. Started Aug 2023; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT05926570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926570.